Clinical trial

Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96%…

NCT00462462 · Orfagen, Industry · Completed

Key facts

NCT number NCT00462462
Title Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.
Official title Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.
Lead sponsor Orfagen, Industry
Collaborators FDA Office of Orphan Products Development U.S. Fed
Status Completed
Phase Phase 2
Study type Interventional
Conditions Congenital Venous Malformation
Intervention type Drug
Interventions Ethanol 96% Gel, Ethanol 98% Solution
Enrollment 32
Start date May 1, 2007
Primary completion Jun 1, 2010
Completion Jun 1, 2010
First posted Apr 19, 2007
Last update posted Jan 15, 2015
Countries France, United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies